Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2017, Article ID 2962794, 5 pages
https://doi.org/10.1155/2017/2962794
Case Report

The Diagnosing Challenge of a Positive ANCA Vasculitis in the Paediatric Age

1Paediatric and Neonatal Intensive Care Service, Centro Materno Infantil do Norte, Centro Hospitalar do Porto, Porto, Portugal
2Paediatric Service, Hospital da Senhora da Oliveira, Guimarães, Portugal
3Otorhinolaryngology Service, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
4Paediatric Service, Centro Materno Infantil do Norte, Centro Hospitalar do Porto, Porto, Portugal
5Department of Paediatric Nephrology, Paediatric Service, Centro Materno Infantil do Norte, Centro Hospitalar do Porto, Porto, Portugal

Correspondence should be addressed to Clara Preto; moc.liamtoh@oterpmaralc

Received 29 July 2017; Revised 10 October 2017; Accepted 23 November 2017; Published 19 December 2017

Academic Editor: Alberto Spalice

Copyright © 2017 Clara Preto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. M. Gardner-Medwin, P. Dolezalova, C. Cummins, and T. R. Southwood, “Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins,” The Lancet, vol. 360, no. 9341, pp. 1197–1202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Dolezalová, P. Telekesová, D. Nemcová, and J. Hoza, “Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey,” Journal of Rheumatology, vol. 31, no. 11, pp. 2295–2299, 2004. View at Google Scholar
  3. P. F. Weiss, “Pediatric vasculitis,” Pediatric Clinics of North America, vol. 59, no. 2, pp. 407–423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Laxer, D. D. Sherry, and P. J. Hashkes, Pediatric Rheumatology in Clinical Practice, Springer-Verlag, London, UK, 2nd edition edition, 2016.
  5. L. A. Plumb, L. Oni, S. D. Marks, and K. Tullus, “Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management,” Pediatric Nephrology, vol. 33, no. 1, pp. 25–39, 2017. View at Publisher · View at Google Scholar
  6. D. Eleftheriou and P. A. Brogan, “Vasculitis in children,” Best Practice & Research Clinical Rheumatology, vol. 23, no. 3, pp. 309–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Cabral, D. L. Canter, E. Muscal et al., “Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener’s): an ARChiVe Cohort Study,” Arthritis & Rheumatology, vol. 68, no. 10, pp. 2514–2526, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Seo and J. H. Stone, “The antineutrophil cytoplasmic antibody-associated vasculitides,” The American Journal of Medicine, vol. 117, no. 1, pp. 39–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Eleftheriou, E. D. Batu, S. Ozen, and P. A. Brogan, “Vasculitis in children,” Nephrology Dialysis Transplantation, vol. 30, no. 1, pp. 94–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. E. C. Hagen, M. R. Daha, J. Hermans et al., “Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization,” Kidney International, vol. 53, no. 3, pp. 743–753, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Berden, A. Göçeroğlu, D. Jayne et al., “Diagnosis and management of ANCA associated vasculitis,” BMJ, vol. 344, p. e26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Mahr and M. de Menthon, “Classification and classification criteria for vasculitis: achievements, limitations and prospects,” Current Opinion in Rheumatology, vol. 27, no. 1, pp. 1–9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. N. M. Wilkinson, J. Page, A. G. Uribe, V. Espinosa, and D. A. Cabral, “Establishment of a pilot pediatric registry for chronic vasculitis is both essential and feasible: a Childhood Arthritis and Rheumatology Alliance (CARRA) survey,” Journal of Rheumatology, vol. 34, no. 1, pp. 224–226, 2007. View at Google Scholar
  14. A. G. Uribe, A. M. Huber, S. Kim et al., “Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis,” Journal of Rheumatology, vol. 39, no. 8, pp. 1687–1697, 2012. View at Google Scholar
  15. G. G. Hunder, W. P. Arend, D. A. Bloch et al., “The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction,” Arthritis & Rheumatism, vol. 33, no. 8, pp. 1065–1067, 1990. View at Google Scholar
  16. M. Frosch and D. Foell, “Wegener granulomatosis in childhood and adolescence,” European Journal of Pediatrics, vol. 163, no. 8, pp. 425–434, 2004. View at Publisher · View at Google Scholar
  17. S. Ozen, A. Pistorio, S. M. Lusan et al., “EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria,” Annals of the Rheumatic Diseases, vol. 69, no. 5, pp. 798–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Ozen, N. Ruperto, M. J. Dillon et al., “EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides,” Annals of the Rheumatic Diseases, vol. 65, no. 7, pp. 936–941, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Watts, S. Lane, T. Hanslik et al., “Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies,” Annals of the Rheumatic Diseases, vol. 66, no. 2, pp. 222–227, 2007. View at Google Scholar
  20. P. J. Klemmer, W. Chalermskulrat, M. S. Reif, S. L. Hogan, D. C. Henke, and R. J. Falk, “Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis,” American Journal of Kidney Diseases, vol. 42, no. 6, pp. 1149–1153, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Jayne, G. Gaskin, N. Rasmussen et al., “Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis,” Journal of the American Society of Nephrology, vol. 18, no. 7, pp. 2180–2188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Lee, A. Gasim, V. K. Derebail et al., “Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure,” Clinical Journal of the American Society of Nephrology, vol. 9, no. 5, pp. 905–913, 2014. View at Publisher · View at Google Scholar · View at Scopus